Black Diamond Therapeutics (BDTX) Cash from Investing Activities Growth (3y) (2022 - 2026)
Black Diamond Therapeutics (BDTX) Cash from Investing Activities Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -29.84% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 38.24% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -22.09% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - | -7.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.71% |
| Dec 31, 2025 | -48.04% |
| Sep 30, 2025 | -16.03% |
| Jun 30, 2025 | -70.84% |
| Mar 31, 2025 | -20.06% |
| Dec 31, 2024 | -13.73% |
| Sep 30, 2024 | -60.54% |
| Jun 30, 2024 | -75.15% |
| Mar 31, 2024 | -81.24% |
| Dec 31, 2023 | 56.63% |
| Sep 30, 2023 | -117.16% |
| Jun 30, 2023 | 27.27% |
| Dec 31, 2022 | 951.62% |
| Sep 30, 2022 | 997.19% |
| Jun 30, 2022 | 2,047.52% |
| Mar 31, 2022 | 1,087.58% |